COMMUNIQUÉS West-GlobeNewswire

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients as Young as 2 Years Old
20/12/2024
BOSTON, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases [...]
Press Release: Sequana Medical announces results of Extraordinary General Meeting of Shareholders and update on Convertible Financing
20/12/2024
Sequana Medical announces results of Extraordinary General Meeting of Shareholders and update on Convertible Financing Ghent, Belgium – 20 December 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " [...]
Syntekabio to Showcase AI-Driven Drug Discovery Solutions at Biotech Showcase 2025
20/12/2024
NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Syntekabio (KOSDAQ: 226330), a leading artificial intelligence (AI)-driven drug development company, is pleased to announce its participation in Biotech Showcase 2025, taking [...]
Avextra Backs Landmark Psilocybin Therapy Study in Palliative Care
20/12/2024
News Release Exclusive Industry Role : Avextra is the industry partner in a groundbreaking project focused on psychedelic-assisted therapy for patients in palliative care suffering from depression. Pioneering Research [...]
Comprehensive Healthcare Leader Joins NAMI Washington Board of Directors
20/12/2024
YAKIMA, Wash., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Comprehensive Healthcare is pleased to announce that Cassidy Brown, director of marketing and communications, has been appointed to the National Alliance of Mental [...]
ALK – Financial calendar for the 2025 financial year
20/12/2024
2025 financial calendar for ALK ( ALKB:DC / OMX: ALK B / AKBLF ): 22 January 2025: Silent period 19 February 2025: Annual report 2024 13 March 2025 at 4.00 p.m.: Annual General Meeting to be held at ALK Bøge Allé 1 2970 [...]
Result of AGM
20/12/2024
DXS INTERNATIONAL PLC (AQSE: DXSP) Result of DXS AGM 2024 The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital clinical decision support systems [...]
Balt secures €355 million to refinance its debt and accelerate its growth
20/12/2024
PARIS and MONTMORENCY, France, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Balt, a global medical device leader in interventional neuroradiology, announces that it has secured €355 million in financing from a group of leading [...]
HNL Lab Medicine’s Angel Tree Program Brings Holiday Magic to Families in Need
20/12/2024
ALLENTOWN, Pa., Dec. 20, 2024 (GLOBE NEWSWIRE) -- In the true spirit of the holidays, HNL Lab Medicine proudly celebrates the continued success of its Angel Tree initiative, now in its fourth and most impactful year. [...]
Compass Health Celebrates Second Donation from Longtime Partner for its State-of-the-Art Regional Center for Intensive Behavioral Health Needs
20/12/2024
The donation marks an end-of-year funding milestone as the non-profit enters the final stages of construction for Phase II of its Broadway Campus Redevelopment, which is set to open in summer 2025 EVERETT, Wash., Dec. [...]
Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering
20/12/2024
ASHBURN, Va., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today [...]
Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis
20/12/2024
Unique cell-impermeable 1 design extends life-saving treatment for dialysis patients Merit to host a WRAPSODY informational call on January 28, 2025 SOUTH JORDAN, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Merit Medical [...]
Monopar Therapeutics Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants
20/12/2024
WILMETTE, Ill., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR) (“Monopar” or the “Company”) , a clinical-stage biotechnology company focused on developing innovative treatments for patients [...]
Channel Therapeutics Highlights Differences Between NaV1.7 and NaV1.8 in Light of Recent Clinical Data on Suzetrigine
20/12/2024
FREEHOLD, N.J., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Channel Therapeutics Corporation, (“Channel” or the “Company”), (NYSE American: CHRO), a pioneer in the development of non-opioid pain treatment therapeutics, is [...]
BioAtla, Inc. Announces Registered Direct Offering to Advance Two Mid-Stage Clinical Programs to Key Inflection Points
20/12/2024
SAN DIEGO, Dec. 20, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB) , a global clinical-stage biotechnology company (“BioAtla” or the “Company”) focused on the development of Conditionally Active Biologic (CAB) [...]
Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection
20/12/2024
Renovaro will Establish the GEDi CUBE Next Generation Nvidia Blackwell Cluster with Nebul's certified AI Healthcare Cloud solutions LOS ANGELES, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB) , a pioneer [...]
HWH International Inc. and Sharing Services Global Corporation see opportunity in Robotics
20/12/2024
BETHESDA, MD, Dec. 20, 2024 (GLOBE NEWSWIRE) -- HWH International Inc. (“HWH”) (Nasdaq: HWH) and its partner Sharing Services Global Corporation (“SHRG”) (OTC: SHRG) are taking further steps in their collaboration in [...]
Light-it Group Launches Enlighten Ventures: A Micro-VC Initiative to Propel Healthtech Innovation
20/12/2024
Javier Lempert (CTO & Founder), Alan Brande (CEO & Founder) and Martin Oppenheimer (COO & Founder) at Light-it’s HQ. AVENTURA, Fla., Dec. 20, 2024 (GLOBE NEWSWIRE) -- Light-it Group, a leading innovator in [...]
IO Biotech secures up to €57.5 million in debt financing from the European Investment Bank
20/12/2024
Funds expected to be used to advance IO Biotech’s immune-modulating therapeutic cancer vaccines, including potential BLA submission for IO102-IO103 in 2025 Commitment is part of the European Investment Bank’s strategy [...]

Pages